Mayinglong Pharmaceutical Group Co., Ltd.

SHSE:600993 Rapporto sulle azioni

Cap. di mercato: CN¥11.6b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Mayinglong Pharmaceutical Group Gestione

Gestione criteri di controllo 2/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

Youzhang Xia

Amministratore delegato

CN¥1.8m

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEOn/a
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

What Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) P/E Is Not Telling You

Aug 19
What Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) P/E Is Not Telling You

Mayinglong Pharmaceutical Group's (SHSE:600993) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 24
Mayinglong Pharmaceutical Group's (SHSE:600993) Shareholders Will Receive A Bigger Dividend Than Last Year

Mayinglong Pharmaceutical Group (SHSE:600993) Has A Rock Solid Balance Sheet

Jun 19
Mayinglong Pharmaceutical Group (SHSE:600993) Has A Rock Solid Balance Sheet

Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Price Is Right But Growth Is Lacking After Shares Rocket 26%

May 07
Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Investors Don't See Light At End Of Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Tunnel

Mar 22
Investors Don't See Light At End Of Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Tunnel

AMMINISTRATORE DELEGATO

Youzhang Xia (45 yo)

no data

Mandato

CN¥1,800,000

Compensazione

Mr. Youzhang Xia serves as General Manager and Director at Mayinglong Pharmaceutical Group Co., Ltd. and served as its Deputy General Manager and Secretary of the Board.